Search for: "Grant, et al v. Wyeth, et al"
Results 41 - 60
of 75
Sorted by Relevance
|
Sort by Date
2 Nov 2011, 2:00 am
Research & Diagnostic Systems (Pharma Patents) US: Roundup Ready® Soybeans: Patent exhaustion in self-replicating biotechnologies (IP Osgoode) US: FDA continues efforts to expand power over intrastate commerce (FDA Law Blog) US: Defendants’ persistence in pursuing “baseless inequitable conduct claim” justified award of attorneys’ fees to plaintiff: Pfizer et. al v. [read post]
16 Jun 2010, 9:49 pm
Opinion below (Supreme Court of Wisconsin) Petition for certiorari Brief in opposition Petitioner’s reply Amicus brief of the Criminal Justice Legal Foundation Amicus brief of the Institute for Justice Amicus brief of the National Association of Home Builders et al. [read post]
15 Feb 2010, 2:20 pm
Opinion below (6th Circuit) Petition for certiorari (09-533) Petition for certiorari (09-547) Brief in opposition (09-533/547) Brief in opposition for the federal respondent (09-533/547) Petitioners’ reply (09-533) Petitioners’ reply (09-547) Amicus brief of members of Congress (09-533/547) Amicus brief of American Mosquito Control Association et al. (09-533/547) Amicus brief of Aquatic Ecosystem Restoration Foundation… [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’:… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’:… [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting:… [read post]
1 Nov 2018, 8:00 am
Supreme Court’s decision in Wyeth v. [read post]
1 Nov 2010, 2:46 am
DIRECTV, Inc., et al. [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs) Products Cepham –… [read post]
17 Nov 2010, 1:48 am
McNeil (EPLAW) Zymar (Gatifloxacin) – US: Allergan fails to secure new trial in Zymar case: Senju et al v Apotex (Patent Docs) [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
3 Mar 2012, 5:36 pm
Minn. 2008)(noting that some but not all courts have concluded relative risks under two support finding expert witness’s opinion to be inadmissible) XYZ, et al. v. [read post]
31 Mar 2007, 9:11 am
Glaxo-SmithKline, et al., No. 06-1111, slip op. [read post]
18 Mar 2011, 10:04 am
Wyeth-Ayherst Laboratories, 513 F. [read post]
22 Aug 2012, 5:00 am
Wyeth, LLC et al., 2012 WL 338715 (N.D. [read post]
27 Oct 2011, 4:24 am
The Supreme Court held in Wyeth v. [read post]
29 Dec 2010, 12:54 pm
Wyeth, Inc. v. [read post]
5 Jun 2013, 5:29 am
Mass. 1986)(granting summary judgment), aff’d, 830 F.2d 1190, 1197 (1st Cir. 1987)(distinguishing between chances that “somewhat favor” plaintiff and plaintiff’s burden of showing specific causation by “preponderant evidence”) DeLuca v. [read post]
